Rapid Combo Test

TORCH IgM Antibody (TOXO, Rubella, CMV, HSV-I, HSV-II) Combo Rapid Test

Simultaneous detection of IgM antibodies against TORCH pathogens.

CE Certified
ISO 13485
Main image of TORCH IgM Antibody (TOXO, Rubella, CMV, HSV-I, HSV-II) Combo Rapid Test

Why Choose reOpenTest Infectious Disease Kits?

Our tests are engineered for accuracy, reliability, and ease of use, ensuring confidence in every result.

Comprehensive TORCH IgM Screening

Detects IgM antibodies for TOXO, Rubella, CMV, HSV-I, and HSV-II.

Convenient Sample

Easy to use with serum or plasma.

Rapid Results

Provides results in 15-20 minutes.

Product Overview

The TORCH IgM Antibody Combo Rapid Test is an in vitro diagnostic device designed for the qualitative detection of IgM antibodies to Toxoplasma gondii, Rubella virus, Cytomegalovirus (CMV), Herpes Simplex Virus type 1 (HSV-I), and Herpes Simplex Virus type 2 (HSV-II) in human serum or plasma.

Technical Specifications

Detection Target IgM antibodies to Toxoplasma gondii, Rubella virus, Cytomegalovirus (CMV), Herpes Simplex Virus type 1 (HSV-I), and Herpes Simplex Virus type 2 (HSV-II)
Sample Type Serum or Plasma
Methodology Immunochromatography
Detection Range Positive/Negative
Reaction Time 15-20 minutes
Storage Conditions 2-30u00b0C
Shelf Life 24 months

Procedure & Interpretation

Step-by-Step Procedure

  1. Add the appropriate buffer to the specimen well.
  2. Add the sample to the sample well.
  3. Wait 15-20 minutes.
  4. Read and interpret the results.

Result Interpretation

Positive Result
Positive: Presence of lines indicates the presence of IgM antibodies to one or more of the TORCH pathogens.
Negative Result
Negative: Absence of lines indicates the absence of IgM antibodies to the tested TORCH pathogens.
Invalid Result
Invalid: If no control line appears, the test is invalid and should be repeated.

Frequently Asked Questions

A positive IgM result suggests a recent or active infection with one or more of the TORCH pathogens. Consult a healthcare professional for further testing and management.

IgM antibodies can indicate a recent infection that could potentially harm the developing fetus. Early detection enables timely intervention.

This test provides a rapid screening result. Confirmatory testing with other methods may be necessary for a definitive diagnosis.

Technical Documents

Download product inserts and brochures for detailed information.

No technical documents are available at this time. Please check back soon.

Partner with reOpenTest

Provide your clients and patients with reliable diagnostic solutions.
Contact us today for bulk pricing and distribution opportunities.

Become a Distributor